in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Aesica partners with Durham and Leeds universities to commercialize API manufacturing technology
7:35 AM MST | December 18, 2012 | Deepti Ramesh
Aesica Pharmaceuticals (Newcastle upon Tyne, UK), the University of Durham (Durham, UK), and the University of Leeds (Leeds, UK) were jointly awarded the METRC innovation grant to investigate and accelerate the development of processes that will improve cost efficiencies and increase manufacturing capacity at Aesica’s Cramlington, UK, site. The new partnership with the University of Durham and the University of Leeds will aim to develop new or improved routes for the manufacture of an active pharmaceutical ingredient (API), Aesica says. A detailed kinetic...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee